Form 8-K - Current report:
SEC Accession No. 0001437749-25-021906
Filing Date
2025-07-02
Accepted
2025-07-02 12:35:49
Documents
14
Period of Report
2025-06-30
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20250701_8k.htm   iXBRL 8-K 42899
2 EXHIBIT 4.1 ex_835779.htm EX-4.1 184565
  Complete submission text file 0001437749-25-021906.txt   402573

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20250630.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20250630_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20250630_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20250630_pre.xml EX-101.PRE 11584
16 EXTRACTED XBRL INSTANCE DOCUMENT bcda20250701_8k_htm.xml XML 2824
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 251099349
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)